Guangzhou University of Chinese Medicine, Guangzhou, China.
National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Medicine (Baltimore). 2022 Oct 28;101(43):e31234. doi: 10.1097/MD.0000000000031234.
Dry eye disease (DED) is a condition occurring worldwide. Studies have found that coronavirus disease 2019 (COVID-19) patients may have persistent dry eye symptoms for weeks and months after recovery, and the prevalence of dry eye is higher in COVID-19 patients than in people without COVID-19 infection. As one of the common ophthalmic diseases, the clinical application of acupuncture in the treatment of DED is not widely used nowadays.
According to the retrieval strategies, randomized controlled trials (RCT) on the acupuncture for DED after recovery from COVID-19 were obtained from Embase, The Cochrane Library, Web of Science, Chinese National Knowledge Infrastructure database, Chinese Biomedical Database, Chinese Science and Technology Periodical database, The WanFang database. Studies were screened based on inclusion and exclusion criteria, and the Cochrane risk bias assessment tool was used to evaluate the quality of the studies. The meta-analysis was performed using Review Manager (RevMan 5.3) and STATA 14.2 software. Ultimately, the evidentiary grade for the results will be evaluated.
The study will provide a high-quality and convincing assessment of the efficacy and safety of acupuncture for DED after recovery from COVID-19 and will be published in peer-reviewed journals.
Our findings will provide references for future clinical decision and guidance development.
干眼疾病(DED)是一种在全球范围内发生的疾病。研究发现,新冠肺炎(COVID-19)患者在康复后可能会持续数周甚至数月出现干眼症状,而且 COVID-19 患者的干眼患病率高于未感染 COVID-19 的人群。作为常见的眼科疾病之一,针灸在治疗 DED 中的临床应用尚未得到广泛应用。
根据检索策略,从 Embase、The Cochrane Library、Web of Science、中国知网数据库、中国生物医学文献数据库、中国科技期刊数据库、万方数据库中获取 COVID-19 康复后针灸治疗 DED 的随机对照试验(RCT)。根据纳入和排除标准筛选研究,并使用 Cochrane 风险偏倚评估工具评估研究质量。使用 Review Manager(RevMan 5.3)和 STATA 14.2 软件进行荟萃分析。最终,将对结果进行证据等级评估。
该研究将对 COVID-19 康复后针灸治疗 DED 的疗效和安全性进行高质量和令人信服的评估,并发表在同行评议期刊上。
我们的研究结果将为未来的临床决策和指南制定提供参考。